1408075-19-3 Usage
General Description
Tert-butyl 7-amino-2-azaspiro[3.5]nonane-2-carboxylate is a chemical compound known for its complex structure. tert-butyl 7-amino-2-azaspiro[3.5]nonane-2-carboxylate, often used in research, falls under the organic compound class and is specifically categorized as an azaspiro compound. Its structure includes an amino group (-NH2), a carboxylate ester group (-COO-), and a tert-butyl group, making it a derivative of azaspiro[3.5]nonane. The properties of this chemical, like its reactivity and solubility, can vary significantly based on its specific contextual environment like temperature and pH. Detailed information about hazards or its potential usage in various fields is not readily available, indicating that it is primarily used in specific scientific research contexts.
Check Digit Verification of cas no
The CAS Registry Mumber 1408075-19-3 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,4,0,8,0,7 and 5 respectively; the second part has 2 digits, 1 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1408075-19:
(9*1)+(8*4)+(7*0)+(6*8)+(5*0)+(4*7)+(3*5)+(2*1)+(1*9)=143
143 % 10 = 3
So 1408075-19-3 is a valid CAS Registry Number.
1408075-19-3Relevant articles and documents
B-LACTAMASE INHIBITOR AND APPLICATION THEREOF
-
, (2018/03/07)
The present invention relates to a compound of Formula (I)-(IV) useful as β-lactamase inhibitor, a pharmaceutically acceptable salt, ester, solvate or stereoisomer thereof, wherein R1, R2, M and ring A have definitions as those in the specification. The present invention further relates to methods for preparing these compounds, pharmaceutical compositions comprising these compounds, and uses of these compounds. For example, the compounds of the present invention can be used as β-lactamase inhibitors, for treatment and/or prophylaxis of diseases caused by bacterial infections, solving drug-resistance problems caused by β-lactamases, especially bacterial drug-resistant diseases caused by type B metallo-β-lactamases.